Dr. Martens (LON:DOCS) Sets New 52-Week High – What’s Next?

Dr. Martens plc (LON:DOCS)’s share price hit a new 52-week high during mid-day trading on Friday . The company traded as high as GBX 84 ($1.13) and last traded at GBX 83.86 ($1.13), with a volume of 1542027 shares. The stock had previously closed at GBX 82.60 ($1.11).

Analyst Ratings Changes

A number of brokerages have issued reports on DOCS. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating on shares of Dr. Martens in a research note on Friday, July 11th. Royal Bank Of Canada reduced their price objective on shares of Dr. Martens from GBX 7,000 ($94.07) to GBX 6,000 ($80.63) and set a “sector perform” rating on the stock in a research note on Monday, May 19th.

Dr. Martens Stock Up 1.5%

The firm’s 50 day moving average price is GBX 72.10 and its two-hundred day moving average price is GBX 64.45. The company has a market cap of £813.50 million, a P/E ratio of 11.88, a price-to-earnings-growth ratio of 6.40 and a beta of 0.11. The company has a debt-to-equity ratio of 127.27, a quick ratio of 1.13 and a current ratio of 2.85.

Dr. Martens (LON:DOCS) last posted its quarterly earnings data on Thursday, June 5th. The company reported GBX 2.40 ($0.03) earnings per share for the quarter. Dr. Martens had a net margin of 7.89% and a return on equity of 18.91%. Equities research analysts anticipate that Dr. Martens plc will post 2.5809394 EPS for the current fiscal year.

Dr. Martens Company Profile

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally
produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical
movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history.